Company Filing History:
1 out of 20 
1 out of 1 Years Active: 2018
Title: The Innovative Contributions of Danny Carrero
Introduction
Danny Carrero is an accomplished inventor based in New York, NY (US). He holds a patent that showcases his innovative approach to cancer treatment. His work focuses on enhancing the effectiveness of chemotherapeutic agents through advanced delivery methods.
Latest Patents
Carrero's notable patent is titled "Poloxamer-based intralesional injections for the delivery of chemotherapeutic agents." This invention involves intralesional injections that incorporate poloxamer compounds along with anticancer drugs. The combination of these components provides a synergistic effect, allowing for lower dosages of active drugs while enhancing treatment effectiveness. The poloxamer-based injections are designed for treating various types of cancer in both humans and animals. They can be utilized as a standalone therapy or in conjunction with other treatments, including chemotherapy, electrotherapy, immunotherapy, and radiation therapy. Additionally, these injections can be employed in virotherapy and gene therapy, offering flexibility in treatment options. The formulations are designed for either immediate or controlled release of the active drugs, facilitating local or systemic administration.
Career Highlights
Throughout his career, Danny Carrero has worked with notable organizations, including Professional Compounding Centers of America and Best Pet Rx Inc. His experience in these companies has contributed to his expertise in developing innovative medical solutions.
Collaborations
Carrero has collaborated with professionals in the field, including his coworker Chris V Simmons. Their joint efforts have likely contributed to the advancement of his patented technologies.
Conclusion
Danny Carrero's contributions to the field of cancer treatment through his innovative patent demonstrate his commitment to improving therapeutic methods. His work exemplifies the potential of combining advanced materials with established medical practices to enhance patient outcomes.